Form 8-K - Current report:
SEC Accession No. 0001193125-24-051235
Filing Date
2024-02-29
Accepted
2024-02-28 20:37:00
Documents
15
Period of Report
2024-02-28
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d776053d8k.htm   iXBRL 8-K 24709
2 EX-99.1 d776053dex991.htm EX-99.1 121745
  Complete submission text file 0001193125-24-051235.txt   283550

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cprx-20240228.xsd EX-101.SCH 2871
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cprx-20240228_lab.xml EX-101.LAB 17994
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cprx-20240228_pre.xml EX-101.PRE 11275
17 EXTRACTED XBRL INSTANCE DOCUMENT d776053d8k_htm.xml XML 3685
Mailing Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Filer) CIK: 0001369568 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33057 | Film No.: 24698384
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)